Cardlytics CEO Transition & Board Changes
Ticker: CDLX · Form: 8-K · Filed: Nov 4, 2024 · CIK: 1666071
| Field | Detail |
|---|---|
| Company | Cardlytics, Inc. (CDLX) |
| Form Type | 8-K |
| Filed Date | Nov 4, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $30,000, $10,000, $165,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, leadership, board-of-directors
Related Tickers: CDLX
TL;DR
New CEO K. Brent Turner takes over Cardlytics Nov 4th, Lynne Laube out. Board also shuffled.
AI Summary
Cardlytics, Inc. announced on October 30, 2024, a series of executive and board changes. These include the appointment of K. Brent Turner as Chief Executive Officer, effective November 4, 2024, and the resignation of Lynne Laube from her CEO role. Additionally, the company elected new directors and adjusted its compensation arrangements.
Why It Matters
This filing signals a significant leadership change at Cardlytics, which could impact the company's strategic direction and operational execution.
Risk Assessment
Risk Level: medium — Leadership changes and board restructuring can introduce uncertainty regarding future strategy and performance.
Key Players & Entities
- Cardlytics, Inc. (company) — Registrant
- K. Brent Turner (person) — Appointed Chief Executive Officer
- Lynne Laube (person) — Resigned Chief Executive Officer
- October 30, 2024 (date) — Date of Report
- November 4, 2024 (date) — Effective date for new CEO
FAQ
Who has been appointed as the new CEO of Cardlytics?
K. Brent Turner has been appointed as the new Chief Executive Officer of Cardlytics, Inc.
When does the new CEO's appointment become effective?
The appointment of K. Brent Turner as CEO is effective November 4, 2024.
Who is stepping down as CEO?
Lynne Laube is resigning from her role as Chief Executive Officer.
What other significant changes were reported by Cardlytics?
Cardlytics also reported the election of new directors and adjustments to compensatory arrangements for certain officers.
What is the date of this Form 8-K filing?
This Form 8-K filing was made as of November 4, 2024, reporting events from October 30, 2024.
Filing Stats: 803 words · 3 min read · ~3 pages · Grade level 10.5 · Accepted 2024-11-04 16:04:26
Key Financial Figures
- $30,000 — Ms. Gupta will be entitled to receive a $30,000 annual retainer for her service as dire
- $10,000 — ainer for her service as director and a $10,000 annual retainer for her service as a me
- $165,000 — t award with a grant date fair value of $165,000 (provided that in no event will the awa
Filing Documents
- cdlx-20241030.htm (8-K) — 29KB
- cdlx-20241030_g1.jpg (GRAPHIC) — 26KB
- 0001666071-24-000158.txt ( ) — 241KB
- cdlx-20241030.xsd (EX-101.SCH) — 3KB
- cdlx-20241030_def.xml (EX-101.DEF) — 14KB
- cdlx-20241030_lab.xml (EX-101.LAB) — 25KB
- cdlx-20241030_pre.xml (EX-101.PRE) — 15KB
- cdlx-20241030_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Cardlytics, Inc. Date: November 4, 2024 By: /s/ Alexis DeSieno Alexis DeSieno Chief Financial Officer (Principal Financial and Accounting Officer)